Sitemap
- Home
-
Science
- Cardiovascular diseases
-
CNS
- NICE Epilepsy Guidelines 2021: Diagnosis and Investigations
- NICE Guidelines 2021: Epilepsy Treatment Protocols
- Differentiating Depression from Bipolar Disorder
- Deep Brain Stimulation and Electromagnetic Interference
- Nice Guideline Algorithm: Epilepsy Care For Children
- A recent head-to head trial comparing the effectiveness of valproate versus levetiracetam
- EEG Cases - Idiopathic Generalized Epilepsy
- EEG Cases - Focal Epilepsy From the Left Hemisphere
- Understanding frequency and types of Electrocardiogram(EKG) abnormalities during routine Electroencephalogram (EEG)*
- AI Based, Personalized Epilepsy Management
- EPILEPSIES: DIAGNOSIS & MANAGEMENT
- Epileptic seizure detection using machine learning classifiers
- Management of anxiety in PWE
- Valproic acid and psychiatric co-morbidities
- Old still stands strong
- The broad Spectrum and Widely used AED
- Management of anxiety in PWE
- Comparing the effectiveness of VPA vs. LEV
- Management of epilepsy with newer AEDs
- New-onset epilepsy in the elderly
- COVID 19 Era: Importance of telemedicine in PWE
- AED Withdrawal Risk Retrieval Calculator
- In-house hospital management of status epilepticus in India
- Recommendation for the treatment of epilepsy in adult and pediatric patients
- Noninvasive detection of hippocampal epileptiform activity on scalp electroencephalogram
- EPI health
- Comparison of treatment guidelines vs real-world observations: India
- Importance of AED medication by Prof. Martin Brodie
-
Diabetes
- International Diabetes Management Practices Study (IDMPS)
- BE-SMART: An Indian DELPHI Expert Opinion on Insulin Initiaition
- BESMART (Basal Early Strategies to Maximize HbA1c Reduction with Oral Therapy)
- AACE/ACE guidelines on insulin initiation 2020
- American Diabetes Association guidelines on insulin initiation 2021
- LANDMARC Study - EASD 2020
- Fasting during Ramadan in patients with diabetes
- Insulin initiation and titration during COVID 19
- Fix Fasting First
- Improving Adherence to Insulin
- Intensification with Basal Insulin
- Basal or premix insulin?
- Management of Hypoglycemia
- Timely Insulinization
- LANDMARC study – 1 year follow-up results
- One-year follow-up results of LANDMARC study – disclosed at ADA 2021
- RSSDI Update 2021
- IDF'21 Quick Read: Patient Challenges & Treatments in T2DM
- IDF'21-Quick Read: Expert Views & Opinions in T2DM
- IDF'21 Quick Read: Clinical Pearls for Your Diabetes Practice
- Is there a need of glycemic marker beyond HbA1c?
- It’s time for change, Its Time in Range!
- Top 10 reads: Link between stress and Diabetes
- New technologies in diabetes care and management: Dr. Vijay Viswanathan
- New technologies in diabetes care and management: Dr. Jothydev Kesavadev
- New technologies in diabetes care and management: Dr. Kalyan Kumar Gangopadhyay
- New technologies in diabetes care and management: Dr. Sunil M Jain
- Implications of TIR on physician perception and practices
- Time-in-range and outcomes beyond glycemic control
- Presenting diabetes RWE patient profile insights - Volume 1
- Making strides: The clinical value of time in range – Tadej Battelino
- Implications on Clinical Practice
- AACE Annual Meeting 2022 Coverage
- Telemedicine: A new norm in diabetes management by Dr. A Ramachandran
- Telemedicine: A new norm in diabetes management by Dr. K M Prasanna Kumar
- Telemedicine: A new norm in diabetes management by Dr. Uday Phadke
- Implications of TIR on clinical practice
- Presenting diabetes RWE patient profile insights - Volume 2
- Time and targets: Innovative approaches to diabetes management
- InRange: Comparison of the second-generation basal insulin analogues with type 1 diabetes using continuous glucose monitoring
- Implementing personalized medicine in diabetes management: Dr. Bipin Sethi
- Implementing personalized medicine in diabetes management: Dr. Manoj Chadha
- Implementing personalized medicine in diabetes management: Dr. Subhash Wangnoo
- Implementing personalized medicine in diabetes management: Dr. J. J. Mukherjee
- Presenting diabetes RWE therapy insights: Volume 3
- ADA 2022: Top 7 Sessions Coverage
- ENDO 2022 - Annual Conference Coverage
- Exploring the evidence: 2nd generation basal insulin analogs by Alice Y.Y. Cheng
- Diabetes RWE therapy insights: Volume 4
- Online patient perception management - Dr. Krishna G Seshadri
- Online patient perception management - Dr. Sanjay Kalra
- Online patient perception management - Dr. Unnikrishnan AG
- Online patient perception management - Dr. V Mohan
- Top 10 reads on depression and diabetes
- Top 10 reads: Diabetes reversal is now a reality!
- Top 10 reads: Foot complications associated with diabetes
- Diabetes real-world evidence insights: Volume 5
- Diabetes real-world evidence insights: Volume 6
- Background to InRange study: Richard M Bergenstal
- Study design and baseline characteristics in InRange study
- InRange webinar bytes 3: Primary and safety results by Dr. T Battelino and E. Renard
- InRange webinar bytes 4: Conclusions and implications by Dr P. Choudhary
- Diabetes real-world evidence patient profile insights - ADA 2022: Volume 1
-
Gut Health
- Bacillus clausii in the prevention of antibiotic-associated diarrhoea in children: A pooled analysis of controlled clinical trials
- Bacillus clausii in the treatment of acute community-acquired diarrhoea among Latin American children (cadiLAc)
- CODDLE study: Bacillus clausii as an adjunctive treatment of acute community-acquired diarrhoea in Filipino children
- Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials
- Probiotics and food intolerance: Going behind the wall
- Probiotic use with antibiotics in kids and adults
- Management of rotavirus diarrhoea in children
- Compositional quality and potential gastrointestinal behavior of probiotic products
- Role of probiotics in immunity and beyond gut by Dr. Ender and Dr. Pramod Jog
- Probiotics in antibiotic-associated dysbiosis by Dr. Patricio Acosta
- Damage to gut microbiome and long-term implications: What can we say conclusively? - By Dr. Jossie Rogacion, Dr. Abkari Abdelhak, Dr. Randy Urtula, Dr. Rashna Dass Hazarika and Dr. Ramesh Srinivasan
- Unlocking the mysteries of the human microbiome to combat COVID-19
- The role of gut microbiota in clinical complications, disease severity and treatment response in severe alcoholic hepatitis
- Early-life lung and gut microbiota and RSV Infection: What is the connection?
- New insights into the role of oral microbiota dysbiosis in the pathogenesis of inflammatory bowel disease
- Gut microbiota in patients with polycystic ovary syndrome: A systematic review
- Emerging role of gut microbiota in functional gastrointestinal disorders
- Dietary SCFAs immunotherapy: Reshaping the gut microbiota in diabetes
- Association of gut microbiota with inflammatory bowel disease and COVID-19 severity: A possible outcome of the altered immune response
- Effect of probiotic fermented dairy products on incidence of respiratory tract infections: A systematic review and meta-analysis of randomized clinical trials
- Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence
- Antibiotic exposure, gut microbiota and the impact of probiotics supplements in neonates: A randomised controlled trial
- The role of the microbiome in asthma inception and phenotype
- Clostridioides difficile infection and gut dysbiosis: Interpreting the interplay in adults and neonates
-
Kidney Transplant
- Recent advances in induction immunosuppression: Part 1: Dr. E. Steve Woodle
- Infections after transplant: Dr. Subramanian Swaminathan
- Induction Immunosuppression for better outcomes in renal transplantation: Current updates: Part 1: Dr. Daniel C. Brennan
- Induction Immunosuppression for better outcomes in renal transplantation: Current updates: Part 2: Dr. Daniel C. Brennan
- NOTTO Guidelines for Transplant Recipients on COVID‑19 Vaccination
- Antibody response of solid organ transplant recipients after 2-dose of SARS-CoV-2 mRNA vaccine
- Algorithms, AI, and machine learning: New horizons for predicting long-term outcomes: Presented at the ESOT 2021 congress
- Minimizing allograft rejection in renal transplantation
- Early steroid withdrawal protocols
- Today’s challenges for improving graft survival - Presented at the ESOT 2021 congress
- Management strategies and outcomes in renal transplant recipients recovering from COVID-19: A retrospective, multicentre, cohort study
- Relevance of donor specific antibody monitoring after kidney transplantation
- COVID-19 pandemic research opportunities in India
- Post transplant infections and its management: Dr. Umapati N. Hedge
- Antibody mediated rejection - Diagnosis and management: Dr. (Prof.) Dinesh Khullar
- To characterize the impact and landscape of infections post kidney transplantation
- Antibody mediated rejection: Recent advances: Dr. E. Steve Woodle
- ABOi renal transplant: Dr. Vijay Kher
- Medically complex living kidney donors where we stand: Dr. Vijay Sinha
- Grafalon® vs. Thymoglobuline® as an induction agent in renal transplantation – A retrospective study
- r-ATG induces human lymphocyte activation, proliferation, and apoptosis in the absence of complement: An experimental study
- Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation
- Making ABOiKT affordable: The NH experience by Dr. Deepak S Ray
- Clinical perspectives towards improving risk stratification strategy for renal transplantation outcomes in Indian patients
- The role of long-lived plasma cells in antibody-mediated rejection of kidney transplantation: An update
-
Otolaryngeal Disorders
- Auricle Schwannoma: Presentation of a rare case and review of existing literature
- Future considerations and directions for thermal ablative technologies
- Vasomotor rhinitis: A form of neurogenic non-allergic rhinitis
- Latest abstracts in otolaryngeal medicine - March 2022
- Otolaryngology scanner: March 2022
- Chronic suppurative otitis media
- Evaluation and management of nasal valve collapse - An update
- Tuberculosis otitis media in a patient with multiple cerebral tuberculomas: A case report
- Latest abstracts in otolaryngeal medicine - April 2022
- Otolaryngology scanner - April 2022
- An extensive unilateral nasal mass: Septal schwannoma - Case report
- Clinical significance of video head impulse test in benign paroxysmal positional vertigo: A meta analysis
- Does allergy cause chronic rhinosinusitis with nasal polyps?
- Otolaryngology scanner - May 2022
- Latest abstracts in otolaryngology - May 2022
- Increasing prevalence of allergic disease and its impact on current practice
- COVID-19 nasopharyngeal swab-related CSF rhinorrhoea: A case report
- Effect of sinus opacification on the severity of obstructive sleep apnea
- Common ear diseases
- Otolaryngology Scanner - July 2022
-
Pediatric Disorders
- Thromboembolism in children with multisystem inflammatory syndrome: A literature review
- Characteristics of the bacterial microbiota in the upper respiratory tract of children
- Fluid/Electrolyte/Acid-base abnormalities
- Aseptic meningitis, hepatitis and cholestasis induced by trimethoprim/sulfamethoxazole: A case report
- What is beyond Salmonella gastroenteritis: A case of acute pancreatitis complicating Salmonella infection in a child - A case report and literature review
- Acute pulmonary infections
- The enigma of new daily persistent headache: What solutions for paediatric age?
- Vital signs as physiomarkers of neonatal sepsis
-
Respiratory Diseases
- Endobronchial lung volume reduction therapies
- Shrinking lung syndrome caused by systemic lupus erythematosus: A case report
- Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm play a role?
- Pulmonoscope: March 2022
- Pulmonology scanner: March 2022
- Targeting molecular and cellular mechanisms in steroid-resistant asthma
- Effects of medication use on small airway function and airway inflammation in patients with clinically controlled asthma
- Not all abolished lung sliding are pneumothorax: The case of a particular lung atelectasis
- Pulmonoscope - April 2022
- Pulmonology scanner - April 2022
- Rationale and clinical use of bronchodilators in adults with bronchiectasis
- Pulmonology scanner - May 2022
- Ceftolozane/Tazobactum induced leukocytosis and clinical failure in a patient being treated for ventilator-associated pneumonia caused by carbapenem-resistant Pseudomonas aeruginosa: A case report
- Lower airways: Assessment and treatment of cough
- Aspiration pneumonia in children with neurological disorders: A new indication for lung ultrasound? A case series
- Shifts in asthma evaluation and management during COVID-19
- Treatment of acute respiratory failure in patient with congestive heart failure and pneumonia
- Pulmonoscope - May 2022
- Undiagnosed chronic obstructive pulmonary disease is highly prevalent in patients referred for dobutamine stress echocardiography with shortness of breath
- Pulmonology scanner - July 2022
- Pause The Atopic March (PAM): Module 1
- Pause The Atopic March (PAM): Module 2
- Cutting-Edge Science
-
-
2021
-
Podcast
- Decoding the VTE enigma: Learnings from COVID 19. Episode 2: Dr. Abhay Bhave and Prof. Roopen Arya
- Decoding the VTE enigma: Learnings from COVID 19. Episode 1: Dr. Abhay Bhave and Prof. Roopen Arya
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 1 - Dr. Abhay Bhave and Prof. Juan Arcelus
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 2 - Dr. Abhay Bhave and Prof. Juan Arcelus
- Decoding the VTE enigma: Learnings from COVID 19. Episode 3: Dr. Abhay Bhave and Prof. Roopen Arya
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 3 - Dr. Abhay Bhave and Prof. Juan Arcelus
- VTE prevention in surgical settings: A top priority in clinicians checklist. Episode 4 - Dr. Abhay Bhave and Prof. Juan Arcelus
-
Article
- 1st largest study of kidney transplantation in COVID-19 survivors
- Evaluation of kidney allograft rejection management practices in USA
- Thromboprophylaxis in surgical patients
- Thromboprophylaxis in cancer patients
- Thromboprophylaxis in hospitalized medically ill patients
- RISE Registry Abstract Presented at 58th ERA-EDTA Congress, June 5-8, 2021
- Anticoagulation in COVID-19: Mayo
- Risk factors for VTE in medically ill
- Rentsch newsletter - anticoagulation and mortality in COVID
- Implementing thromboprophylaxis in medically ill
- Garfield ASIA VTE study
- CHEST webinar: COVID-19 and VTE: Key takeaways
- Recent updates in the management of thromboembolism: Newsletter
- COVID-19 & VTE
- MediBYTES December 2021- Recent updates in the management of thromboembolism
- MediBYTES January 2022 - Recent updates in the management of thromboembolism
- MediBYTES February 2022 - Recent updates in the management of thromboembolism
- VTE in surgery
- Implementing thromboprophylaxis in patients with cancer
-
Video
- Kidney transplantation from COVID recovered donors
- Kidney transplantation from COVID recovered recipients
- Management of kidney transplantation: Evolving evidence and strategies: Part 3 - Tolerance protocols
- Management of kidney transplantation: Evolving evidence and strategies: Part 2 - Subclinical rejection
- Management of kidney transplantation: Evolving evidence and strategies: Part 1 - COVID update and vaccination
- rATG as induction therapy in renal transplantation: Indian clinical experience from RISE registry
- VTE prophylaxis in surgical patient population: Dr. David Jimenez, Dr. Suviraj John, Dr. V. Balaji
- Cancer-associated thrombosis (CAT): Updates and recommendations - Dr. Lisa K. Moores, Dr. Mammen Chandy, Dr. Abhay A. Bhave
- VTE prophylaxis in medically-ill hospitalized settings: Dr. Tobias Tritschler, Dr. S. K. Todi, Dr. Ravindra M. Mehta
- The role of thromboprophylaxis for the prevention of VTE: Prof. Gregoire Le Gal
- Primary VTE prophylaxis in patients with cancer undergoing major abdominal/pelvic surgery: Prof. Juan Arcelus
- Prophylactic strategies for VTE in gynecological cancer surgeries
- VTE risk assessment in surgical patients: Prof. Joseph A Caprini
- CHEST webinar: COVID-19 and VTE: From observations to guidelines to changing clinical practices: Do we still know enough?
- VTE in surgery: From risk assessment to appropriate thromboprophylaxis - Dr. David Jimenez, Dr. Vinay K. Kapoor, Dr. Shailesh V. Shrikhande
-
Podcast
-
- Are we oblivious to the second leading cause of mortality in cancer. Episode 1: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
- Are we oblivious to the second leading cause of mortality in cancer. Episode 2: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
- 3 T approach for PE management
- PE case reports
- Implementing thromboprophylaxis in surgical patients
- 3 T approach for PE management: Dr. Janine Vintch, Dr. Prachee Sathe, Dr. Ravindra Mehta
- Are we oblivious to the second leading cause of mortality in cancer? Episode 3: Dr. Abhay Bhave and Lt. Gen (Dr) Velu Nair (Retd)
- MediBYTES June 2022 - Recent updates in the management of thromboembolism
- Thromboprophylaxis in special cases among medically ill
- VTE risk assessment models
- Risk factors for VTE in cancer
- Adopting a pragmatic approach to VTE management among medical patients. Episode 1 - Dr. Abhay Bhave and Dr. S K Todi
- Adopting a pragmatic approach to VTE management among medical patients. Episode 2 - Dr. Abhay Bhave and Dr. S K Todi
- Adopting a pragmatic approach to VTE management among medical patients. Episode 3 - Dr. Abhay Bhave and Dr. S K Todi
- Case study: Extended prophylaxis in cancer surgery
- Risk factors for VTE in surgery
- Indian VTE registries
- Moving the needle in cancer-associated thrombosis, updates & recommendations. Dr. Lisa Baumann Kreuziger, Dr. Abhay Bhave, Lt. Gen (Dr) Velu Nair (Retd)
- Moving the needle in cancer associated thrombosis, updates & recommendations
- MediBYTES July 2022 - Recent updates in the management of thromboembolism
- Case study: VTE prophylaxis in CAT
- Thromboprophylaxis in special considerations among cancer patients
- Approach to thromboprophylaxis in medical settings: Taking the learnings forward (Dr Tobias Tritschler, Dr Ashish Bhalla, Dr Bharat Jagiasi)
- Approach to thromboprophylaxis in medical settings: Taking the learnings forward
- Managing VTE risk post-surgery: Situations that warrant special care. Episode 1 - Dr. Abhay Bhave and Dr. Samama Charles Marc
- MediBYTES August 2022 - Recent updates in the management of thromboembolism
- Thromboprophylaxis in surgical cases
- VTE prophylaxis in non onco general (abdominal) surgery
- MediBYTES September 2022 Recent updates in the management of thromboembolism
-
2021
- Thrombosis
-
Patient Support
-
Patient Support
-
2021
- Article
-
Video
- 10 things to remember while visiting the doctor during COVID-19
- Steps to administer Toujeo® with TouStar® pen
- Steps to administer Toujeo® with SoloStar® pen
- Steps to administer Lantus® with SoloStar® pen
- Steps to administer Lantus® with AllStar® pen
- Exercises to help manage blood glucose
- Sample meal plan for people with diabetes
- Managing diabetes during festivals
- Managing diabetes at workplace
- Managing diabetes at home
- Self-monitoring blood glucose level
- Managing Hypoglycemia and Hyperglycemia
- Traveling with insulins
- How should insulin pen be stored?
- Importance of injection site rotation
- Kidney transplantation patient education (English)
- Kidney transplantation patient education (Hindi)
-
- Pulses - A smart way to safely control blood glucose levels
- Smart exercises to stay fit and safely keep diabetes in check
- Smart recipes to safely manage sweet cravings
- Smart tips for safe hypoglycemic control
- Smart ways to safely boost the immune system
- Smart ways to safely enjoy the mango season
- Smart winter foods to safely manage diabetes
- Smartly fight belly fat to safely control sugar
- SAFE and SMART tips for people with diabetes to start their exercise routine
- Guidance for diabetes management
- SAFE and SMART tips for newly diagnosed people with diabetes
- Smart ways to safely enjoy the Christmas and New Year festivities
- Smart ways to safely manage diabetes during Christmas
- Smart ways to enjoy Suhoor safely and stay healthy
- Enjoy a safe and healthy Iftar with smart tips
- Smart ways to prevent hypoglycemia and safely celebrate Ramadan
- Smart tips to enjoy a safe, healthy and happy Ganesh Chaturthi
- Smart diet choices to enjoy a safe and healthy festive season
- Smart dietary advice to enjoy a safe Navaratri
- Smart tips to satisfy monsoon cravings safely
- A smart guide to manage stress caused by diabetes
- Denial, a major risk factor when it comes to diabetes
- Help your patient with diabetes eat mindfully
- Smart and simple ways to manage hypoglycaemia
- Complex medication routine in diabetes simplified
-
2021
- Patient Support Articles/Videos
- CNS
- Diabetes
- Kidney Transplant
- Otolaryngeal Disorders
- Respiratory Diseases
-
Patient Support
-
Products
-
Allegra® Group
- Allegra®: Innovative solutions because we truly care
- Allegra® nasal spray: Key features
- Allegra®-M: Only bioequivalent bilayered fexofenadine - montelukast combination published in IJPS
- Reasons to choose Allegra® nasal spray over traditional nasal sprays
- Efficacy and safety of fexofenadine in alleviating pollution aggravated allergic rhinitis
- Evidence for bioequivalent-bilayered Allegra®-M leading to improved treatment and compliance
- Review of sensory attributes and patient preferences of Allegra® nasal spray compared with other INCs
- Allegra®-120
- Allegra®-180
- Allegra®-M
- Allegra® Nasal Duo
- Allegra® Nasal
- Allegra® Suspension
- SMART management of allergic rhinitis: Clinical secrets from Prof. Richard Harvey (Sydney)
- Amaryl® & Combinations
-
Apidra®
- Benefits of Apidra® over Regular Human Insulin (RHI)
- Apidra® - Better PPG control in hospitalized patients
- Apidra® for faster and better PPG control
- New real-world evidence on benefits of changing meal-time insulin therapy to insulin glulisine
- Apidra® - Flexibility benefit to patients, with better PPG control
- The only zinc-free formulation in rapid-acting insulin analogs
- Apidra® - Faster onset and flexible dosing window for better PPG control
- Differential benefits of Apidra in obese patients
- Basal bolus therapy with Lantus® and Apidra® provides more physiological insulin response over twice daily premix
- Basal plus therapy Lantus® and Apidra® provides lesser nocturnal hypoglycemia over twice daily premix therapy
- Superior glycemic control with basal bolus therapy
- More patients reached target A1c on basal plus insulin therapy
- Insulin glulisine injection: Apidra® and Apidra® Solostar®
- Results from PASSION study 2022
- Cardace®
- Clexane®
- Enterogermina®
- Frisium®
-
Lantus®
- Lantus®: Safer and convenient vs. human premix insulin
- 6 unique reasons to choose basal insulin during COVID-19 pandemic
- Lantus® + OADs: More effective for glycemic control vs. human premix insulin
- Latest real-world evidence from India presented at EASD 2020: LANDMARC
- 5 unique reasons to choose Lantus® over biosimilars during COVID 19 pandemic.
- Fix fasting first: Two decades of evidence of optimal glycemic control with Lantus®
- Which insulin to choose while initiating T2DM patients during COVID-19 challenging time?
- Lantus®: The optimal insulin during COVID-19 pandemic
- Why should Lantus® be the No. 1 choice of insulin?
- Achieving adequate glycemic control during lockdown with basal insulin
- Insulin glargine injection I.P: Lantus® SoloStar and Lantus®
- Steps to administer Lantus® with SoloStar pen
- Steps to administer Lantus® with AllStar pen
- Synvisc-One™
- Targocid®
- Thymoglobuline®
-
Toujeo®
- Patient-friendly, reusable Toustar® pen
- Patient-friendly, disposable Solostar® pen
- Toujeo® dose calculation - Initiation and titration
- Toujeo® offers dosing flexibility
- Evidences on Toujeo® vs. Gla-100 on hypoglycemia
- 6 simple steps to use TouStar® pen
- Advantages of Toujeo® in patients with diabetes during Ramadan fast
- Toujeo® Monograph
- Glycemic variability of Toujeo® vs. Gla-100
- Glycemic variability of Toujeo® vs. IDeg-100
- Mechanism Of Action - Toujeo®
- Glycemic variability - Toujeo®
- Insulin glargine injection Toujeo® Solostar®
- Time-in-range: The new glycemic marker
- ATOS: Real-world evidence
- Valparin®
- Vinlep™
- Vinlep™ Suspension
- View all products
-
Allegra® Group
- Beyond Therapy
- Registration
- Login
- My Account
- Search
- Sitemap
- Why Register